NASDAQ:ARYA - ARYA Sciences Acquisition Corp III Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$11.16
+0.30 (1.20%)
Get New ARYA Sciences Acquisition Corp III Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ARYA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ARYA

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for ARYA Sciences Acquisition Corp III in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $11.16.

This chart shows the closing price for ARYA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in ARYA Sciences Acquisition Corp III. This rating has held steady since May 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/5/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/4/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/2/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/31/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/31/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/5/2020Chardan CapitalInitiated CoverageBuy$28.00High
(Data available from 9/27/2016 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/1/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/31/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/29/2021
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/29/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/28/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/27/2021

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.

ARYA Sciences Acquisition Corp III

ARYA Sciences Acquisition Corp III does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.
Read More

Today's Range

Now: $11.16
Low: $10.77
High: $11.25

50 Day Range

MA: $10.66
Low: $9.91
High: $11.16

52 Week Range

Now: $11.16
Low: $9.82
High: $25.89

Volume

366,228 shs

Average Volume

320,123 shs

Market Capitalization

$186.48 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of ARYA Sciences Acquisition Corp III?

The following Wall Street analysts have issued research reports on ARYA Sciences Acquisition Corp III in the last twelve months:
View the latest analyst ratings for ARYA.

What is the current price target for ARYA Sciences Acquisition Corp III?

0 Wall Street analysts have set twelve-month price targets for ARYA Sciences Acquisition Corp III in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for ARYA Sciences Acquisition Corp III in the next year.
View the latest price targets for ARYA.

What is the current consensus analyst rating for ARYA Sciences Acquisition Corp III?

ARYA Sciences Acquisition Corp III currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for ARYA.

How do I contact ARYA Sciences Acquisition Corp III's investor relations team?

ARYA Sciences Acquisition Corp III's physical mailing address is 51 ASTOR PLACE 10TH FLOOR, NEW YORK NY, 10003. The company's listed phone number is 212-284-2300. The official website for ARYA Sciences Acquisition Corp III is www.perceptivelife.com.